Market Research Logo

Malaysia Pharmaceuticals & Healthcare Q2 2019

Malaysia Pharmaceuticals & Healthcare Q2 2019

Key View:

Government investment will support future growth of the Malaysian pharmaceutical and healthcare industry. Malaysia's2019 budget proposes an increase in public healthcare expenditure, and the government will continue to push forward withfundamental healthcare initiatives. However, we note that innovative drugmakers will continue to struggle due to the country'schallenging regulatory environment in addition to growing generic substitution rhetoric as the rationalisation of the pharmaceuticalbudget becomes more important.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Chemical Company Of Malaysia
Kotra Pharma
Novartis
Ranbaxy Malaysia
Sanofi
Malaysia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report